Behavioral psychedelics: Integrating mind and behavior to improve health and resilience

The authors of this free full-text opinion piece write "One of the most recent and potentially promising advancements in the health sciences has involved the attempted use of psychedelics for treating mental and behavioral health problems, such as anxiety, depression, posttraumatic stress disorder, and addiction. Despite surging scientific and public interest in this work, however, we presently have no standard of care or consensus regarding how best to combine psychotherapy and psychedelics or to assess effectiveness. We discuss these timely issues here through the lens of behavioral psychedelics, which we define as the study of psychedelics to foster intentional changes in habits and behaviors to improve health and resilience. Psychedelics may have the potential to reduce chronic disease risk caused by mental and behavioral rigidity. To fully realize this potential, though, we believe the field must establish best practices and guidelines that include how to induce lasting changes in behavior ... Psychedelic compounds have the potential to turbocharge the process of transforming the mind, and the race to realize their benefits is in full swing. To maximize these benefits, we believe this work should include behavior as a treatment target with measurable treatment metrics to establish best practices and guidelines. Focusing on behavior will lead to more rigorous research on psychedelics but, most importantly, it will also help change what is most responsible for maintaining chronic disease."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers

Next
Next

Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review